Ftse Mib
35.041,96
0,70%
DAX
20.270,87
0,66%
S&P 500
5.836,22
0,16%
NASDAQ
19.088,10
-0,38%
Bitcoin
95.291,55
0,83%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Rhythm Pharmaceuticals Inc (RYTM) Rhythm Pharmaceuticals Inc (RYTM) Notizie

Rhythm Pharmaceuticals Inc

RYTM
54,89
0,00 (0,00%)
14 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202513:17EDGAR2Form 8-K - Current report
10/1/202513:15GLOBERhythm Pharmaceuticals Announces Preliminary Fourth Quarter..
20/12/202420:15GLOBERhythm Pharmaceuticals Announces FDA Approval of IMCIVREE®..
03/12/202412:00GLOBERhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide)..
18/11/202413:00GLOBERhythm Pharmaceuticals Announces Five Presentations at ESPE..
14/11/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202403:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14/11/202400:30GLOBERhythm Pharmaceuticals Announces Publication of Results from..
13/11/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
12/11/202413:55EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202422:36EDGAR2Form 144 - Report of proposed sale of securities
06/11/202423:07EDGAR2Form 144 - Report of proposed sale of securities
06/11/202414:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:00GLOBERhythm Pharmaceuticals Announces Participation in Upcoming..
05/11/202422:02EDGAR2Form 8-K - Current report
05/11/202422:01GLOBERhythm Pharmaceuticals Reports Third Quarter 2024 Financial..
04/11/202422:01GLOBERhythm Pharmaceuticals Announces Five New Data Presentations..
24/10/202412:00GLOBERhythm Pharmaceuticals and Axovia Therapeutics Announce..
23/10/202414:00GLOBERhythm Pharmaceuticals to Report Third Quarter 2024..
08/10/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
19/9/202422:49EDGAR2Form 8-K - Current report
16/9/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
11/9/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202422:26EDGAR2Form 144 - Report of proposed sale of securities
26/8/202414:02GLOBERhythm Pharmaceuticals Announces FDA Acceptance for Priority..
26/8/202414:00GLOBERhythm Pharmaceuticals to Present at Wells Fargo Healthcare..
14/8/202422:06EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
13/8/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
09/8/202422:09EDGAR2Form 144 - Report of proposed sale of securities
07/8/202412:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/8/202412:00EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
06/8/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202413:00EDGAR2Form 8-K - Current report
06/8/202413:00GLOBERhythm Pharmaceuticals Reports Second Quarter 2024 Financial..
31/7/202415:10GLOBERhythm Pharmaceuticals Announces European Commission Expands..
30/7/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/7/202414:00GLOBERhythm Pharmaceuticals Announces First Patients Dosed in..
23/7/202413:30GLOBERhythm Pharmaceuticals to Report Second Quarter 2024..
18/7/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/7/202422:37EDGAR2Form 144 - Report of proposed sale of securities
16/7/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202422:34EDGAR2Form 144 - Report of proposed sale of securities
11/7/202422:01GLOBERhythm Pharmaceuticals Announces New Employment Inducement..
10/7/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/7/202422:07EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 54,89

La tua Cronologia

NASDAQ
RYTM
Rhythm Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network